Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy.

Schubert C, Pryds A, Zeng S, Xie Y, Freund KB, Spaide RF, Merriam JC, Barbazetto I, Slakter JS, Chang S, Munch IC, Drack AV, Hernandez J, Yzer S, Merriam JE, Linneberg A, Larsen M, Yannuzzi LA, Mullins RF, Allikmets R.

Hum Mutat. 2014 Jul;35(7):859-67. doi: 10.1002/humu.22551.

2.

Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy.

Miki A, Kondo N, Yanagisawa S, Bessho H, Honda S, Negi A.

Ophthalmology. 2014 May;121(5):1067-72. doi: 10.1016/j.ophtha.2013.11.020. Epub 2013 Dec 21.

PMID:
24365176
3.

Characterization of subretinal fluid leakage in central serous chorioretinopathy.

Pryds A, Sander B, Larsen M.

Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5853-7. doi: 10.1167/iovs.09-4830. Epub 2010 May 26.

PMID:
20505211
4.

Changes in choroidal thickness after systemic administration of high-dose corticosteroids: a pilot study.

Han JM, Hwang JM, Kim JS, Park KH, Woo SJ.

Invest Ophthalmol Vis Sci. 2014 Jan 21;55(1):440-5. doi: 10.1167/iovs.13-12854.

PMID:
24370828
5.

[Analysis of fundus fluorescein angiography, indocyanine green angiography and choroidal thickness in central serous chorioretinopathy].

Li L, Li DH, Yang ZK, Bian AL, Chen YX, Dong FT.

Zhonghua Yan Ke Za Zhi. 2012 Oct;48(10):878-82. Chinese.

PMID:
23302240
6.

[Changes of choroidal thickness in central serous chorioretinopathy].

Yang LH, Tian B, Shi XH, Ding N, Zhou D, Wei WB.

Zhonghua Yan Ke Za Zhi. 2012 Oct;48(10):874-7. Chinese.

PMID:
23302239
7.

Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.

Jirarattanasopa P, Ooto S, Tsujikawa A, Yamashiro K, Hangai M, Hirata M, Matsumoto A, Yoshimura N.

Ophthalmology. 2012 Aug;119(8):1666-78. doi: 10.1016/j.ophtha.2012.02.021. Epub 2012 Apr 21.

PMID:
22521082
8.

Thickness of photoreceptor layers in polypoidal choroidal vasculopathy and central serous chorioretinopathy.

Ooto S, Tsujikawa A, Mori S, Tamura H, Yamashiro K, Yoshimura N.

Graefes Arch Clin Exp Ophthalmol. 2010 Aug;248(8):1077-86. doi: 10.1007/s00417-010-1338-5. Epub 2010 Mar 13.

PMID:
20229103
9.

[Central serous chorioretinopathy (CSC) and corticosteroids].

Stoffelns BM, Kramann C, Schoepfer K.

Klin Monbl Augenheilkd. 2008 May;225(5):370-5. doi: 10.1055/s-2008-1027271. German.

PMID:
18454375
10.

An association between central serous chorioretinopathy and gastroesophageal reflux disease.

Mansuetta CC, Mason JO 3rd, Swanner J, Feist RM, White MF Jr, Thomley ML, McGwin G Jr, Emond TL.

Am J Ophthalmol. 2004 Jun;137(6):1096-100.

PMID:
15183795
11.

Variation in the glucocorticoid receptor gene (NR3C1) may be associated with corticosteroid dependency and resistance in children with Crohn's disease.

Krupoves A, Mack D, Deslandres C, Seidman E, Amre DK.

Pharmacogenet Genomics. 2011 Aug;21(8):454-60. doi: 10.1097/FPC.0b013e3283476a01.

PMID:
21633323
12.

Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.

Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF.

Ophthalmology. 2010 Sep;117(9):1792-9. doi: 10.1016/j.ophtha.2010.01.023. Epub 2010 May 15.

PMID:
20472289
13.

Macular pigment optical density in central serous chorioretinopathy.

Sasamoto Y, Gomi F, Sawa M, Tsujikawa M, Hamasaki T.

Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5219-25. doi: 10.1167/iovs.09-4881. Epub 2010 May 5.

PMID:
20445108
14.

Choroidal thickness in central serous chorioretinopathy.

Kuroda S, Ikuno Y, Yasuno Y, Nakai K, Usui S, Sawa M, Tsujikawa M, Gomi F, Nishida K.

Retina. 2013 Feb;33(2):302-8. doi: 10.1097/IAE.0b013e318263d11f.

PMID:
23064424
15.

Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy.

Kim YT, Kang SW, Bai KH.

Eye (Lond). 2011 Dec;25(12):1635-40. doi: 10.1038/eye.2011.258. Epub 2011 Oct 21.

16.

Study of subretinal exudation and consequent changes in acute central serous chorioretinopathy by optical coherence tomography.

Yu J, Jiang C, Xu G.

Am J Ophthalmol. 2014 Oct;158(4):752-756.e2. doi: 10.1016/j.ajo.2014.06.015. Epub 2014 Jun 25.

PMID:
24973608
17.

Corticosteroids and central serous chorioretinopathy.

Carvalho-Recchia CA, Yannuzzi LA, Negrão S, Spaide RF, Freund KB, Rodriguez-Coleman H, Lenharo M, Iida T.

Ophthalmology. 2002 Oct;109(10):1834-7.

PMID:
12359603
18.

Associations Between Topical Ophthalmic Corticosteroids and Central Serous Chorioretinopathy: A Taiwanese Population-Based Study.

Chang YS, Weng SF, Chang C, Wang JJ, Wang JY, Jan RL.

Invest Ophthalmol Vis Sci. 2015 Jun;56(6):4083-9. doi: 10.1167/iovs.14-16360.

PMID:
26114485
19.

Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy.

Iida T, Kishi S, Hagimura N, Shimizu K.

Retina. 1999;19(6):508-12.

PMID:
10606450
20.

Choroidal vessel diameter in central serous chorioretinopathy.

Yang L, Jonas JB, Wei W.

Acta Ophthalmol. 2013 Aug;91(5):e358-62. doi: 10.1111/aos.12059. Epub 2013 May 7.

Items per page

Supplemental Content

Write to the Help Desk